CAMP and neoplasm: It is worth noting that activating TLR8 signal in tumor cells can prevent tumor cells from producing CAMP, reverse the transformation of tumor‐induced initial type, and tumor‐specific T cells into senescent cells, and thus enhance antitumor immunity in vivo.77, 78